Let's review the charts once again.
The maker of wearable fitness devices has seen its stock sprint higher on the buyout news after languishing this summer near multi-year lows.
Heron Therapeutics and TG Therapeutics each gave investors reasons for cheer in the last few days.
TherapeuticsMD and Thor Industries are in wholly unrelated sectors, but both stocks look undervalued over the long term.
It is early in the game but here's what traders can do.
The medical device and health care company is set to resume its long advance, with our first price target at $92 and next at $100.
After correction, the medical device maker could see longer-term gains to the $150-$161 area.
If you are not already long EW or just want to add to longs you should use any minor intraday dip today or tomorrow to buy.
Let's review the charts and indicators of ISRG.
PETS has generated positive operating cash flow for more than a decade and it has been using that cash flow to pay dividends to shareholders.